Retham Technologies Launches Functional Cryopreserved Platelets for Research; Prolytix Named Distributor of Retham Cryoplatelets™
Retham Technologies, Inc. (“Retham”) today announced the launch of its next-generation functional Retham Cryoplatelets™, a novel solution designed to overcome longstanding challenges in platelet-based research. The company also named Prolytix, a leader in coagulation and hematology services and products, to be the distributor of Retham Cryoplatelets.
